-+ 0.00%
-+ 0.00%
-+ 0.00%
According to Zhitong Finance App News, Microchip Biotech (688321.SH) issued an announcement. On November 14, 2026, in accordance with the notice issued by the National Health Insurance Administration and the Ministry of Human Resources and Social Security to issue the “National Medical Insurance Catalogue” (“National Health Insurance Catalogue”) and the “Commercial Health Insurance Innovative Drug Catalogue” (2026), the company's product Siglita sodium tablets (bisulopine®) successfully renewed the “National Health Insurance Catalogue”.
Share
Listen to the news
According to Zhitong Finance App News, Microchip Biotech (688321.SH) issued an announcement. On November 14, 2026, in accordance with the notice issued by the National Health Insurance Administration and the Ministry of Human Resources and Social Security to issue the “National Medical Insurance Catalogue” (“National Health Insurance Catalogue”) and the “Commercial Health Insurance Innovative Drug Catalogue” (2026), the company's product Siglita sodium tablets (bisulopine®) successfully renewed the “National Health Insurance Catalogue”.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending